SITCSection 5
U.S. imports of alkaloid-based medicaments in dosage or retail form (nes) (SITC 54232) totaled $47.9M in April 2026, traded with 30 countries.
Importers of Alkaloid-Based Medicaments in Dosage or Retail Form (NES) paid $178K in duties in April 2026 — an effective duty rate of 10% on $1.8M in dutiable value, based on actual customs collections rather than the published tariff schedule. Alkaloid-Based Medicaments in Dosage or Retail Form (NES) imports of $47.9M in April 2026 ran 25% below the year-to-date monthly average of $63.9M.
Last updated: April 2026 dataAlkaloids and their derivatives—ranging from morphine-class narcotics to ergot compounds—are among the most tightly regulated active pharmaceutical ingredients in international trade, and finished dosage forms or retail packings fall under both FDA drug admissibility review and DEA scheduling controls for controlled substances. Classification under SITC 54232 captures products not elsewhere specified, meaning importers must confirm that no more-specific heading applies before using this code. Documentation requirements typically include FDA drug establishment registration, prior notice, and, for scheduled alkaloids, DEA import permits. Compliance complexity is high: consult a licensed customs broker and verify current FDA and DEA requirements before shipment.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
The NES (not elsewhere specified) qualifier means the product must not fit a more specific SITC heading for alkaloid medicaments. Importers should review the full SITC schedule to confirm no narrower classification applies before declaring under 54232, as misclassification can trigger reclassification and penalty.
FDA reviews admissibility under its drug import authority, requiring the foreign manufacturer to be registered and the product to meet labeling and approval standards. If the alkaloid is a controlled substance (e.g., opioids, cocaine derivatives), a DEA import permit is also mandatory before the shipment can be released.
Supplier Network
Get discovered by U.S. importers searching for HS 54232 — Alkaloid-Based Medicaments in Dosage or Retail Form (NES). Be the first supplier listed.
Monthly import values over time